Detalles de la búsqueda
1.
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Blood;
142(24): 2105-2118, 2023 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562003
2.
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
J Allergy Clin Immunol;
153(1): 287-296, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793572
3.
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
J Allergy Clin Immunol;
153(5): 1423-1431.e2, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290608
4.
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.
Lancet Oncol;
25(3): 376-387, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309282
5.
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.
Clin Immunol;
261: 109942, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367737
6.
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet;
402(10396): 129-140, 2023 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352885
7.
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.
Blood;
139(18): 2758-2769, 2022 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061893
8.
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Blood;
140(7): 685-705, 2022 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671392
9.
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee.
Cytotherapy;
2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483362
10.
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
Cytotherapy;
26(4): 351-359, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349310
11.
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
J Allergy Clin Immunol;
151(2): 547-555.e5, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36456360
12.
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
Blood;
137(6): 848-855, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150379
13.
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering.
Cytotherapy;
25(5): 463-471, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710227
14.
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.
Cytotherapy;
2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38054912
15.
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.
Cytotherapy;
25(9): 977-985, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330731
16.
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.
Cytotherapy;
25(6): 578-589, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941149
17.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood;
135(23): 2094-2105, 2020 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32268350
18.
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
Cytotherapy;
24(3): 249-261, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879990
19.
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes.
Cytotherapy;
24(4): 385-392, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331394
20.
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.
Cytotherapy;
24(4): 428-436, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042670